Screener
Pacific Biosciences of California PACB Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $521.81M.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's market capitalization?
- Pacific Biosciences of California (PACB) reported market capitalization of $521.81M in Q2 2026.
- How has Pacific Biosciences of California's market capitalization changed year-over-year?
- Pacific Biosciences of California's market capitalization increased by 44.9% year-over-year, from $360.1M to $521.81M.
- What is the long-term trend for Pacific Biosciences of California's market capitalization?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's market capitalization has grown at a -35.5% compound annual growth rate (CAGR), from $5.04B to $564.57M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Pacific Biosciences of California's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude